Article

Autocrine Signaling by Receptor Tyrosine Kinases in Urothelial Carcinoma of the Bladder

2020-10-15

Abstract excerpt

Comprehensive characterizations of bladder cancer (BCa) have established molecular phenotype classes with distinct alterations and survival trends. Extending these studies within the tyrosine kinase (TK) family to identify disease drivers could improve our use of TK inhibitors to treat specific patient groups or individuals. We examined the expression distribution of TKs as a class (n = 89) in The Cancer Genome At...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 279772f6-0cfd-5f27-8555-b32d211dc6c8
DOI: 10.1101/2020.10.15.341206

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Autocrine Signaling by Receptor Tyrosine Kinases in Urothelial Carcinoma of the BladderDOI 10.1101/2020.10.15.341206Read

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Semantic proximity Read

EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.Semantic proximity Read

A place for precision medicine in bladder cancer: targeting the FGFRs.Semantic proximity Read

In silico analysis and validation of the cancer-associated fibroblasts-related gene CAMK4 promotes bladder cancer progressionSemantic proximity Read

Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerSemantic proximity Read

FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.Semantic proximity Read

Emerging therapeutic targets in bladder cancer.Semantic proximity Read

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.Semantic proximity Read

Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatmentSemantic proximity Read

Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.Semantic proximity Read

Molecular targets and targeted therapies in bladder cancer managementSemantic proximity Read

Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.Semantic proximity Read